Hai cercato la traduzione di tophi da Inglese a Maltese

crystal enrolled gout patients with measurable tophi.
crystal arrwola pazjenti b’tofi li tista’ titkejjel.

these tophi may cause joint and bone damage.
dawn it-tofi jistgħu jikkawżaw ħsara fil-ġog u fl- għadam.

keeping uric acid levels low for long enough can also shrink tophi.
jekk il- livelli ta 'aċidu uriku jinżammu baxxi għal żmien twil biżżejjed, dan jista' jċekken id- daqs tat- tofi.

seventy-one percent (71%) of patients had baseline tophi.
wieħed u sebgħin fil-mija (71%) tal-pazjenti kellhom tofi fil-linja bażi.

left untreated, larger deposits called tophi may form in and around joints.
jekk ma tiġix ikkurata, jistgħu jiffurmaw depositi akbar magħrufa bħala tofi ġewwa u madwar il-ġogi.

keeping uric acid levels sufficiently low for a long enough period can also shrink tophi.
iż-żamma ta’ uric acid f’livell baxx biżżejjed għall-perjodu twil biżżejjed tista’ wkoll iċċekken it-tofi.

the effect of treatment on tophi was assessed using standardized digital photography and image analysis by a central reader blinded to treatment assignment.
l-effett tal-kura fuq it-tofi kien evalwat bl-użu ta’ fotografija diġitali standardizzata u analiżi tal- immaġni permezz ta’ reader Ċentrali blindati għall-kura assenjata.

across both studies, 61% of patients had mild or moderate renal impairment and 19% had tophi at baseline.
fiż-żewġ studji, 61 % tal-pazjenti kellhom indeboliment renali ħafif jew moderat u 19 % kellhom tofi fil-linja bażi.

once levels of uric acid are below 6 mg/dl, this allows crystals in the joints to dissolve, slowly shrinking the tophi.
ladarba l-livelli ta' aċidu uriku jaqgħu taħt 6 mg/dl, dan jippermetti sabiex il-kristalli fil-ġogi jinħallu, u bil-mod il-mod iċekknu t-tofi.

in patients with tophi or persistent symptoms, the target is less than 5 mg/dl (300 µmol/l).
f’pazjenti b’sintomi tat-tofi jew b’sintomi persistenti, il-mira hija inqas minn 5 mg/dl (300 µmol/l).

this is where high levels of the substance uric acid develop in the blood and then crystallise in joints and tissues, forming tophi (stones) that cause pain and joint damage.
dan iseħħ meta livelli għoljin tal-aċidu uriku tas-sustanza jiżviluppaw fid-demm u mbagħad jikkristalizzaw fil-ġogi u t- tessuti, u jifformaw tofi (ġebliet) li jikkawżaw uġigħ u ħsara fil-ġogi.

adenuric is used in patients who already have signs of a build-up of crystals, including arthritis (pain and inflammation in the joints) or tophi (‘ stones ’, larger deposits of urate crystals that can cause joint and bone damage).
adenuric jintuża f' pazjenti li diġà jkollhom sinjali ta 'akkumulu ta' kristalli, fosthom l- artrite (uġigħ u infjammazzjoni fil- ġogi) jew tofi (tophi, 'ġebliet', depożiti akbar ta 'kristalli ta' l- urat li jistgħu jikkawżaw ħsara fil- ġogi u fl- għadam).